Clorox (NYSE:CLX) Announces Earnings Results

Clorox (NYSE:CLX) issued its earnings results on Monday. The company reported $1.45 earnings per share for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12), Zacks reports. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. Clorox had a return on equity of 316.87% and a net margin of 6.38%. The company’s revenue for the quarter was down 8.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.71 earnings per share. Clorox updated its FY 2025 guidance to 6.950-7.350 EPS.

Clorox Price Performance

NYSE:CLX opened at $138.35 on Tuesday. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The stock has a market capitalization of $17.04 billion, a PE ratio of 37.80, a price-to-earnings-growth ratio of 2.62 and a beta of 0.60. The stock’s 50-day moving average price is $143.85 and its 200-day moving average price is $154.69. Clorox has a 52 week low of $127.60 and a 52 week high of $171.37.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.53%. Clorox’s dividend payout ratio (DPR) is presently 133.33%.

Analyst Ratings Changes

A number of equities analysts have issued reports on CLX shares. DA Davidson cut their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Evercore ISI boosted their price objective on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Barclays cut their target price on shares of Clorox from $139.00 to $134.00 and set an “underweight” rating for the company in a research report on Friday, April 11th. Citigroup lowered their target price on Clorox from $165.00 to $150.00 and set a “neutral” rating for the company in a research note on Monday, April 14th. Finally, UBS Group cut their price objective on Clorox from $176.00 to $154.00 and set a “neutral” rating on the stock in a research report on Thursday, April 17th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, Clorox currently has an average rating of “Hold” and a consensus price target of $153.83.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.